Amfetaminil

Amfetaminil
Clinical data
Trade names	Aponeuron
Other names	Amphetaminil; AN-1; N-Cyanobenzylamphetamine; N-(α′-Cyanobenzyl)amphetamine
Routes of; administration	Oral
Drug class	Stimulant; Appetite suppressant; Norepinephrine–dopamine releasing agent
ATC code	none;
Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible); US: Schedule IV;
Identifiers
	IUPAC name 2-Phenyl-2-(1-phenylpropan-2-ylamino)acetonitrile;
CAS Number	17590-01-1 ;
PubChem CID	28615;
ChemSpider	26613 ;
UNII	0XU0V77JVE;
KEGG	D07446 ;
ChEMBL	ChEMBL2104064 ;
CompTox Dashboard (EPA)	DTXSID80864783 ;
ECHA InfoCard	100.037.767
Chemical and physical data
Formula	C17H18N2
Molar mass	250.345 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N#CC(NC(C)Cc1ccccc1)c2ccccc2;
	InChI InChI=1S/C17H18N2/c1-14(12-15-8-4-2-5-9-15)19-17(13-18)16-10-6-3-7-11-16/h2-11,14,17,19H,12H2,1H3 ; Key:NFHVTCJKAHYEQN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Amfetaminil (also known as amphetaminil, N-cyanobenzylamphetamine, and AN-1; brand name Aponeuron) is a stimulant drug derived from amphetamine, which was developed in the 1970s and used for the treatment of obesity, ADHD, and narcolepsy. It has largely been withdrawn from clinical use following problems with abuse. The drug is a prodrug to amphetamine.